| Drug Name: | Azlocillin (37091-66-0) |
|---|---|
| PubChem ID: | 122130242 |
| SMILES: | CC1([C@@H](N2C(S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C |
| InchiKey: | JTWOMNBEOCYFNV-WULFKBJJSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 461.5 |
| LogP | : | 0.0942 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 6 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 148.15 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Cefotaxime (63527-52-6) | Impaired Renal Function | Antagonistic | Not known | Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category